ATE243479T1 - Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung - Google Patents

Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung

Info

Publication number
ATE243479T1
ATE243479T1 AT00986137T AT00986137T ATE243479T1 AT E243479 T1 ATE243479 T1 AT E243479T1 AT 00986137 T AT00986137 T AT 00986137T AT 00986137 T AT00986137 T AT 00986137T AT E243479 T1 ATE243479 T1 AT E243479T1
Authority
AT
Austria
Prior art keywords
nucleic acid
synthetic surface
present
medical device
endothelialization
Prior art date
Application number
AT00986137T
Other languages
English (en)
Inventor
Mika Lahtinen
Original Assignee
Xenerate Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9904454A external-priority patent/SE9904454D0/xx
Priority claimed from SE9904747A external-priority patent/SE9904747D0/xx
Application filed by Xenerate Ab filed Critical Xenerate Ab
Application granted granted Critical
Publication of ATE243479T1 publication Critical patent/ATE243479T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/258—Genetic materials, DNA, RNA, genes, vectors, e.g. plasmids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Surgery (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Surgical Instruments (AREA)
  • External Artificial Organs (AREA)
  • Eye Examination Apparatus (AREA)
AT00986137T 1999-12-07 2000-12-07 Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung ATE243479T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9904454A SE9904454D0 (sv) 1999-12-07 1999-12-07 Medical implant
SE9904747A SE9904747D0 (sv) 1999-12-07 1999-12-23 Medical Implant
SE0000285A SE0000285D0 (sv) 1999-12-07 2000-01-31 Medical implant
PCT/SE2000/002460 WO2001041674A1 (en) 1999-12-07 2000-12-07 Medical device

Publications (1)

Publication Number Publication Date
ATE243479T1 true ATE243479T1 (de) 2003-07-15

Family

ID=27354498

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00986137T ATE243479T1 (de) 1999-12-07 2000-12-07 Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung

Country Status (12)

Country Link
US (1) US20030059463A1 (de)
EP (1) EP1235536B1 (de)
JP (1) JP2003516180A (de)
CN (1) CN1239133C (de)
AT (1) ATE243479T1 (de)
AU (1) AU782237B2 (de)
CA (1) CA2392284C (de)
DE (1) DE60003580T2 (de)
DK (1) DK1235536T3 (de)
ES (1) ES2206342T3 (de)
SE (1) SE0000285D0 (de)
WO (1) WO2001041674A1 (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030008396A1 (en) * 1999-03-17 2003-01-09 Ku David N. Poly(vinyl alcohol) hydrogel
US6596699B2 (en) 1998-09-22 2003-07-22 Biosurface Engineering Technologies, Inc. Nucleic acid coating compositions and methods
US6368658B1 (en) * 1999-04-19 2002-04-09 Scimed Life Systems, Inc. Coating medical devices using air suspension
US7592017B2 (en) 2000-03-10 2009-09-22 Mast Biosurgery Ag Resorbable thin membranes
US8632583B2 (en) * 2011-05-09 2014-01-21 Palmaz Scientific, Inc. Implantable medical device having enhanced endothelial migration features and methods of making the same
AUPR148400A0 (en) 2000-11-14 2000-12-07 Cochlear Limited Apparatus for delivery of pharmaceuticals to the cochlea
US9089450B2 (en) 2000-11-14 2015-07-28 Cochlear Limited Implantatable component having an accessible lumen and a drug release capsule for introduction into same
DE60133767T2 (de) 2000-11-27 2009-06-25 Dnavec Research Inc., Tsukuba Für fibroblasten-wachstumsfaktor 2 (fgf2) kodierender paramyxovirus-vektor und dessen verwendung
AUPR879201A0 (en) 2001-11-09 2001-12-06 Cochlear Limited Subthreshold stimulation of a cochlea
AU2002356964A1 (en) * 2001-11-14 2003-05-26 Atrium Medical Corporation Graft and method of making
US8048444B2 (en) * 2002-07-31 2011-11-01 Mast Biosurgery Ag Apparatus and method for preventing adhesions between an implant and surrounding tissues
JP2005537909A (ja) * 2002-07-31 2005-12-15 マクロポー バイオサージェリー インコーポレイテッド インプラントと周囲の組織との間の癒着を防ぐための装置及び方法
US7704520B1 (en) * 2002-09-10 2010-04-27 Mast Biosurgery Ag Methods of promoting enhanced healing of tissues after cardiac surgery
AT507045B1 (de) 2002-11-29 2010-04-15 Cochlear Ltd Implantierbare, gewebe-stimulierende vorrichtung
US7627373B2 (en) * 2002-11-30 2009-12-01 Cardiac Pacemakers, Inc. Method and apparatus for cell and electrical therapy of living tissue
US7044965B1 (en) * 2002-12-13 2006-05-16 Spielberg Theodore E Therapeutic cellular stent
US7371256B2 (en) * 2002-12-16 2008-05-13 Poly-Med, Inc Composite vascular constructs with selectively controlled properties
US20060083767A1 (en) * 2003-02-27 2006-04-20 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
US20070015960A1 (en) * 2003-02-28 2007-01-18 Schaerer Mayfield Technologies Gmbh Device for localizing, influencing and guiding of tracking bodies, and method for operating a marking device
US20040230298A1 (en) * 2003-04-25 2004-11-18 Medtronic Vascular, Inc. Drug-polymer coated stent with polysulfone and styrenic block copolymer
EP1653865A2 (de) * 2003-05-23 2006-05-10 Angiotech International Ag Anastomose-verbindungsvorrichtung
DE10328816A1 (de) * 2003-06-21 2005-01-05 Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin Implantierbare Stimulationselektrode mit einer Beschichtung zur Erhöhung der Gewebsverträglichkeit
US20100266663A1 (en) * 2003-09-10 2010-10-21 Calhoun Christopher J Tissue-treating implantable compositions
US8435285B2 (en) * 2003-11-25 2013-05-07 Boston Scientific Scimed, Inc. Composite stent with inner and outer stent elements and method of using the same
CA2558661C (en) * 2004-02-06 2012-09-04 Georgia Tech Research Corporation Load bearing biocompatible device
EP1786485A4 (de) 2004-02-06 2012-05-30 Georgia Tech Res Inst Oberflächengerichtete zellulare anbringung
US7840263B2 (en) * 2004-02-27 2010-11-23 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression
US8293890B2 (en) 2004-04-30 2012-10-23 Advanced Cardiovascular Systems, Inc. Hyaluronic acid based copolymers
US7764995B2 (en) 2004-06-07 2010-07-27 Cardiac Pacemakers, Inc. Method and apparatus to modulate cellular regeneration post myocardial infarct
US20050278025A1 (en) * 2004-06-10 2005-12-15 Salumedica Llc Meniscus prosthesis
US7556800B2 (en) * 2004-07-09 2009-07-07 Viscofan, S.A Universal fishing bait based on filaments or strips of fibrous collagen
US7534422B2 (en) * 2004-07-09 2009-05-19 Viscofan, S.A. Universal fishing bait based on fibrous collagen and the procedure for its preparation
US7729761B2 (en) * 2004-07-14 2010-06-01 Cardiac Pacemakers, Inc. Method and apparatus for controlled gene or protein delivery
EP1621161B1 (de) * 2004-07-28 2009-11-18 Cordis Corporation Bifurkationsprothese zur Reparatur eines Bauchaortenaneurysmas
CN101018512B (zh) * 2004-08-13 2011-05-18 马斯特生物外科股份公司 具有可生物降解区和不可生物降解区的外科手术假体
US20080091277A1 (en) * 2004-08-13 2008-04-17 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
EP1796693A2 (de) * 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantierbare gewebezusammensetzungen und verfahren
US7981065B2 (en) 2004-12-20 2011-07-19 Cardiac Pacemakers, Inc. Lead electrode incorporating extracellular matrix
US8060219B2 (en) * 2004-12-20 2011-11-15 Cardiac Pacemakers, Inc. Epicardial patch including isolated extracellular matrix with pacing electrodes
WO2006125215A2 (en) * 2005-05-19 2006-11-23 Biophan Technologies, Inc. Electromagnetic resonant circuit sleeve for implantable medical device
US20080119877A1 (en) * 2005-08-12 2008-05-22 Kai Deusch Surgical prosthesis having biodegradable and nonbiodegradable regions
US7774057B2 (en) 2005-09-06 2010-08-10 Cardiac Pacemakers, Inc. Method and apparatus for device controlled gene expression for cardiac protection
US20070134204A1 (en) * 2005-12-09 2007-06-14 Henrich Cheng Method for treating nerve injury and vector construct for the same
US9629626B2 (en) * 2006-02-02 2017-04-25 Covidien Lp Mechanically tuned buttress material to assist with proper formation of surgical element in diseased tissue
US20070190028A1 (en) * 2006-02-13 2007-08-16 Jihong Qu Method and apparatus for heat or electromagnetic control of gene expression
DE102006053260A1 (de) * 2006-07-20 2008-01-24 Clinical House Europe Gmbh Implantat zur Verankerung von Zahnersatz
US20080171972A1 (en) * 2006-10-06 2008-07-17 Stopek Joshua B Medical device package
US8133215B2 (en) 2007-08-13 2012-03-13 Cochlear Limited Independently-manufactured drug delivery module and corresponding receptacle in an implantable medical device
CN101474456B (zh) * 2009-02-09 2012-02-22 乐普（北京）医疗器械股份有限公司 一种携载基因的医疗器械的制备方法
CN101502696B (zh) * 2009-02-17 2012-07-11 乐普（北京）医疗器械股份有限公司 一种携载基因和/或药物的医疗器械及其制备方法
US8617097B2 (en) 2010-05-24 2013-12-31 Cochlear Limited Drug-delivery accessory for an implantable medical device
US8597948B2 (en) 2011-03-10 2013-12-03 First Principles, Inc. Cloned biological material medical device and method thereof
EA201390099A1 (ru) 2011-05-26 2013-05-30 Картива, Инк. Конический суставный имплант и относящиеся к нему инструменты
WO2016065245A1 (en) * 2014-10-24 2016-04-28 Incept, Llc Extra luminal scaffold
CA2981064C (en) 2015-03-31 2024-01-02 Cartiva, Inc. Carpometacarpal (cmc) implants and methods
EP3753531A1 (de) 2015-03-31 2020-12-23 Cartiva, Inc. Hydrogelimplantate mit porösen materialien
WO2016168363A1 (en) 2015-04-14 2016-10-20 Cartiva, Inc. Tooling for creating tapered opening in tissue and related methods
JP7414529B2 (ja) 2017-06-07 2024-01-16 シファメド・ホールディングス・エルエルシー 血管内流体移動デバイス、システム、および使用方法
CN111556763B (zh) 2017-11-13 2023-09-01 施菲姆德控股有限责任公司 血管内流体运动装置、系统
EP3746149B1 (de) 2018-02-01 2025-08-06 Shifamed Holdings, LLC Intravaskuläre blutpumpen
WO2020028537A1 (en) 2018-07-31 2020-02-06 Shifamed Holdings, Llc Intravascaular blood pumps and methods of use
CN108938143A (zh) * 2018-08-15 2018-12-07 湖南工业大学 一种三层结构小口径仿生血管及其制备方法
WO2020073047A1 (en) 2018-10-05 2020-04-09 Shifamed Holdings, Llc Intravascular blood pumps and methods of use
WO2021011473A1 (en) 2019-07-12 2021-01-21 Shifamed Holdings, Llc Intravascular blood pumps and methods of manufacture and use
WO2021016372A1 (en) 2019-07-22 2021-01-28 Shifamed Holdings, Llc Intravascular blood pumps with struts and methods of use and manufacture
US12465748B2 (en) 2019-08-07 2025-11-11 Supira Medical, Inc. Catheter blood pumps and collapsible pump housings
DE102019121562B4 (de) * 2019-08-09 2024-01-11 Acandis Gmbh Medizinische Vorrichtung zur Behandlung von Aneurysmen
US12121713B2 (en) 2019-09-25 2024-10-22 Shifamed Holdings, Llc Catheter blood pumps and collapsible blood conduits
EP4501393A3 (de) 2019-09-25 2025-04-09 Shifamed Holdings, LLC Katheterblutpumpen und zusammenklappbare pumpengehäuse
WO2021062265A1 (en) 2019-09-25 2021-04-01 Shifamed Holdings, Llc Intravascular blood pump systems and methods of use and control thereof
EP4072650A4 (de) 2019-12-11 2024-01-10 Shifamed Holdings, LLC Absteigende aorten- und hohlvenenblutpumpen
CN119901559A (zh) * 2025-01-21 2025-04-29 艾联生物科技(杭州)有限公司 一种用于肠炎模型病理共定位评价的染色试剂盒及染色方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208179B1 (en) * 1990-11-27 2007-04-24 The American National Red Cross Methods for treating disease and forming a supplemented fibrin matrix
US5782789A (en) * 1994-10-19 1998-07-21 Atrium Medical Corporation Macrochannel phosthetic/delivery patch
EP1018977B1 (de) * 1995-05-26 2004-12-08 SurModics, Inc. Verfahren und implantierbarer gegenstand zur förderung der endothelialisierung
DE69732304T2 (de) * 1996-11-01 2005-06-02 Ark Therapeutics Ltd. Verwendung von vegf zur herstellung eines medikaments zur behandlung oder verhinderung der intimalen hyperplasie und verabreichungsgerät
US5972027A (en) * 1997-09-30 1999-10-26 Scimed Life Systems, Inc Porous stent drug delivery system
GB9809082D0 (en) * 1998-04-28 1998-06-24 Eurogene Limited Delivery device
CA2351734A1 (en) * 1998-11-20 2000-06-02 University Of Connecticut Generic integrated implantable potentiostat telemetry unit for electrochemical sensors
US6398808B1 (en) * 1999-06-15 2002-06-04 Scimed Life Systems, Inc. Localized delivery of genetic information from biostable materials

Also Published As

Publication number Publication date
DE60003580T2 (de) 2004-05-27
AU2242901A (en) 2001-06-18
DK1235536T3 (da) 2003-10-20
EP1235536B1 (de) 2003-06-25
WO2001041674A1 (en) 2001-06-14
CA2392284C (en) 2009-08-18
JP2003516180A (ja) 2003-05-13
CN1239133C (zh) 2006-02-01
CA2392284A1 (en) 2001-06-14
SE0000285D0 (sv) 2000-01-31
US20030059463A1 (en) 2003-03-27
CN1407873A (zh) 2003-04-02
AU782237B2 (en) 2005-07-14
EP1235536A1 (de) 2002-09-04
DE60003580D1 (de) 2003-07-31
HK1054858A1 (en) 2003-12-19
ES2206342T3 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
ATE243479T1 (de) Medizinische vorrichtung mit nukleinsäurehaltiger synthetischer oberfläche zur in-vivo induktion seiner endothelialisierung
ATE214903T1 (de) Verwendung von perfluorkohlenwasserstoffen zur herstellung von potenzierungsmitteln für die ultraschallvermittelte hyperthermiebehandlung von biologischen geweben
WO2003013239A3 (de) Verfahren zur devitalisierung natürlicher organe und/oder zur bereitstellung extrazellulärer matrices zum 'tissue-engineering'
EP2266501A3 (de) Medizinische Vorrichtungen mit Nanokompositen
WO2002060955A3 (en) Modified antibodies and methods of use
DE69535576D1 (de) Zusammensetzungen von nucleinsäure und viskosität-erhöhendem polymer pvp, zur verwendung in gentherapie
WO2000035371A3 (es) Procedimiento y dispositivo para favorecer el implante de material biologico
DE69333658D1 (de) Verfahren zur behandlung von organen und gewebe
WO2004110360A3 (en) Proteoglycan degrading mutants for treatment of cns
WO2001068811A3 (de) Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
WO1999048536A3 (en) Delivery of long lasting therapeutic agents by forming covalent attachments in vivo
NZ506480A (en) The c-myc coding region determinant-binding protein (crd-bp) and its nucleic acid sequence
Chen et al. Biofabricating hollow microneedle array with controllable microstructure for cell transplantation
ATE172117T1 (de) Verwendung von trospiumchlorid zur herstellung eines arzneimittels zur behandlung von blasenkrankheiten
WO2003039591A3 (de) Allogene vakzine enthaltend eine ein costimulatorisches polypeptid exprimierende tumorzelle
DE69328527D1 (de) Carboxypeptidase-ähnliches Protein aus Knochen und Verfahren zur dessen Herstellung
WO2001082892A3 (de) Wirkstoffhaltige liposome
ATE267843T1 (de) Verfahren zur herstellung von selbstvernetzten hyaluronsäuren und deren derivaten mittels superkritischer anti-lösungsmittel
ATE208420T1 (de) Protein des cadherin-typs aus knochen und verfahren zur herstellung
UA23999C2 (uk) Спосіб одержаhhя засобу "біпекс" для лікуваhhя hейрооhкологічhих захворюваhь
RU2000131320A (ru) Способ подготовки дефекта кожного покрова к аутодермопластике
UA40019A (uk) Вентрикулярний резервуар з титановою пластиною
Schramm AESCULAP Prize for Neurosurgical Research The European Association of Neurosurgical Societies (EANS)
UA36811A (uk) Спосіб визначення антитоксичної здатності замінників шкіри
UA39324A (uk) Спосіб лікування хворих на паркінсонізм

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties